Endothelium‐dependent relaxation evoked by ATP and UTP in the aorta of P2Y2‐deficient mice
Open Access
- 1 March 2006
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 147 (5) , 569-574
- https://doi.org/10.1038/sj.bjp.0706642
Abstract
Based on pharmacological criteria, we previously suggested that in the mouse aorta, endothelium‐dependent relaxation by nucleotides is mediated by P2Y1(adenosine diphosphate (ADP)), P2Y2(adenosine triphosphate (ATP)) and P2Y6(uridine diphosphate (UDP)) receptors. For UTP, it was unclear whether P2Y2, P2Y6or yet another subtype was involved. Therefore, in view of the lack of selective purinergic agonists and antagonists, we used P2Y2‐deficient mice to clarify the action of UTP. Thoracic aorta segments (width 2 mm) of P2Y2‐deficient and wild‐type (WT) mice were mounted in organ baths to measure isometric force development and intracellular calcium signalling. Relaxations evoked by ADP, UDP and acetylcholine were identical in knockout and WT mice, indicating that the receptors for these agonists function normally. P2Y2‐deficient mice showed impaired ATP‐ and adenosine 5′[γ‐thio] triphosphate (ATPγS)‐evoked relaxation, suggesting that in WT mice, ATP and ATPγS activate predominantly the P2Y2subtype. The ATP/ATPγS‐evoked relaxation and calcium signals in the knockout mice were partially rescued by P2Y1, as they were sensitive to 2′‐deoxy‐N6‐methyladenosine 3′,5′‐bisphosphate (MRS2179), a P2Y1‐selective antagonist. In contrast to ATP, the UTP‐evoked relaxation was not different between knockout and WT mice. Moreover, the action of UTP was not sensitive to MRS2179. Therefore, the action of UTP is probably mediated mainly by a P2Y6(like) receptor subtype. In conclusion, we demonstrated that ATP‐evoked relaxation of the murine aorta is mainly mediated by P2Y2. But this P2Y2receptor has apparently no major role in UTP‐evoked relaxation. The vasodilator effect of UTP is probably mediated mainly by a P2Y6(like) receptor. British Journal of Pharmacology(2006)147, 569–574. doi:10.1038/sj.bjp.0706642Keywords
This publication has 25 references indexed in Scilit:
- Pharmacological characterization of nucleotide P2Y receptors on endothelial cells of the mouse aortaBritish Journal of Pharmacology, 2005
- Noradrenaline and extracellular nucleotide cotransmission involves activation of vasoconstrictive P2X1,3- and P2Y6-like receptors in mouse perfused kidneyBritish Journal of Pharmacology, 2005
- Endothelium‐dependent contractions in hypertensionBritish Journal of Pharmacology, 2005
- Extracellular nucleotides induce vasodilatation in human arteries via prostaglandins, nitric oxide and endothelium‐derived hyperpolarising factorBritish Journal of Pharmacology, 2003
- Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor familyTrends in Pharmacological Sciences, 2003
- P2Y1 and P2Y2 receptors are coupled to the NO/cGMP pathway to vasodilate the rat arterial mesenteric bedBritish Journal of Pharmacology, 2002
- P2 receptors: new potential players in atherosclerosisBritish Journal of Pharmacology, 2002
- Pharmacology of INS37217 [P1-(Uridine 5′)-P4- (2′-deoxycytidine 5′)tetraphosphate, Tetrasodium Salt], a Next-Generation P2Y2 Receptor Agonist for the Treatment of Cystic FibrosisThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Constitutive Release of ATP and Evidence for Major Contribution of Ecto-nucleotide Pyrophosphatase and Nucleoside Diphosphokinase to Extracellular Nucleotide ConcentrationsJournal of Biological Chemistry, 2000
- Activity of novel adenine nucleotide derivatives as agonists and antagonists at recombinant rat P2X receptorsDrug Development Research, 2000